Article: 124675 of alt.religion.scientology From: referen@bway.net (Diane Richardson) Newsgroups: alt.religion.scientology Subject: Lawrence J. Brady (Was: Re: ATEG CEO formerly of Hill & Knowlton?) Date: Sat, 11 Apr 1998 03:59:27 GMT Organization: http://extra.newsguy.com Lines: 151 Reply-To: referen@bway.net [** snip **] A short chronology of Lawrence J. Brady's recent career moves: 10 April 1991-- Brady, along with four other executives, leaves Hill & Knowlton to form Capitoline International Group, Ltd. [I don't know if Brady left Capitoline or if Capitoline went out of business. I'll check on that.] 10 Mar 1995 -- Brady named president, chief operating officer, and a director of Chantal Pharmaceutical Corp. (NASDAQ:CHTL). [Chantal Pharmaceutical, peddling its Ethocyn wrinkle cream, skyrocketed and then plummeted on the market. A lot of acrimony, accusations, and finger-pointing took place. I find it interesting that Brady's short career with Chantal usually isn't included in his press release biographies.] 10 Oct 1996 -- Brady named senior advisor to the chairman of the board of Advanced Technologies Group for an initial period of six months.. ATG chairman of the board is John Collins. 20 Mar 1997 -- Brady named president of ATG, replacing Hugo Pomrehn, who has been elevated to the position of vice chairman of the board. Brady is also named a to ATG's board of directors. John Collins remains as chief executive officer and chairman of the board of ATG. [For a small company, it seems loaded with top-level executive positions.] 1 Dec 1997 -- Brady is named chairman of the board, president, and chief executive officer of ATG, replacing John Collins, who is retained as a consultant to ATG. 16 Dec 97 -- Brady issues the following letter to shareholders: December 16, 1997, Tuesday DISTRIBUTION: Business Editors LENGTH: 697 words HEADLINE: American Technologies CEO Comments on the Company's Plan for Growth in 1998 DATELINE: MONROVIA, Calif. Dec. 16, 1997--The following letter to shareholders was released Tuesday by the chairman and chief executive officer of American Technologies Group Inc. (ATG) (OTC:ATEG): -0- December 16, 1997 Dear Shareholder: I recently took over as chairman and chief executive officer of ATG and I did not want this year to close without you receiving a personal note from me. First, on behalf of all of us at ATG, I want to wish you and your family a happy holiday season. I also want to take this opportunity to tell you what we are doing to make ATG a real success in 1998. The recent closing price of ATG's stock can only be described as absurd. The fundamentals of the company are more sound than ever in its eight-year history. The company is poised on the verge of success in a number of applications of its core technologies. The current stock price does not reflect the value of the company and its potential for future growth. On December 6, we held a symposium at which 13 scientists and experts discussed the recent success of the IE technology in coking, scaling, combustion, biological and medical applications. Further study and research needs to be completed in some areas, but there is absolutely no question that this science has been validated and the future of the IE technology is extremely bright. We will be making announcements in the very near future on the company's new marketing strategy to get the products in the market place in the U.S. and internationally. We are in negotiations with national distribution firms on The Force and comparable private label products as well as our household products containing IE-clusters. We have excellent products to sell. Further, we anticipate IE-crystals will be the active ingredient in a new health and beauty line of products now being developed. Additionally, a line of homeopathic products containing IE-crystal is under development. We believe the IE-crystal is the molecular basis for homeopathy. The prototype of the table top water distiller is completed and in our laboratory. Industry reaction is enthusiastic. We are in discussion with some of the largest manufacturing, sales and distribution firms in the world and anticipate concluding negotiations with one or more partners in early 1998. We are confirmed in our earlier belief that the table top distiller will be a major source of revenue for the company. The management team is streamlined, focused and enthusiastic about the company, its science and products. We have outside members on our board of directors whose integrity and reputation are unparalleled. I took over as chairman and chief executive officer of the company two weeks ago. In these two weeks we have transformed the management, redefined the marketing strategy and accelerated the commercialization of our core sciences. The future is bright. I have no doubt that at some point the stock price will accurately reflect the true value of the company. I wanted you to know that my reputation is on the line and you have my solemn commitment that we will only promise what we can deliver and deliver what we promise. You have my very best wishes for a happy holiday season. Sincerely, Lawrence J. Brady Chairman, President and Chief Executive Officer -0- Matters discussed in this release include forward-looking statements that involve risks and uncertainties, and actual results may be materially different. Factors that could cause actual results to differ include activity levels in the securities markets and other risk factors listed in the company's reports to the Securities and Exchange Commission, including its Form 10-QSB and Form 10-KSB on file with the SEC. CONTACT: American Technologies Group Inc. Doug Weil, 626/357-5000 ___________________________________________________ There's tons of public information out there about these companies. I don't want to flood the newsgroup with all of it, since it quickly turns into a morass of raw data. Diane Richardson referen@bway.net